Global Anti-Infective Vaccines Market
Rapidly spreading infectious diseases such as tuberculosis, malaria, Hepatitis B, HIV/AIDS, influenza and others are becoming major concern to the society and the healthcare professionals as they are majorly contributing to worldwide causes of death and presenting huge burden on healthcare systems. Infectious diseases are treated with category of drugs including antivirals and anti-infective agents along with adjunct therapy of immune system boosters.
Rapidly spreading infectious diseases such as tuberculosis, malaria, Hepatitis B, HIV/AIDS, influenza and others are becoming major concern to the society and the healthcare professionals as they are majorly contributing to worldwide causes of death and presenting huge burden on healthcare systems. Infectious diseases are treated with category of drugs including antivirals and anti-infective agents along with adjunct therapy of immune system boosters.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Anti</strong>-<strong>Infective</strong><br />
<strong>Vaccines</strong> <strong>Market</strong><br />
Share, <strong>Global</strong> Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation and Forecast,<br />
2016 – 2026<br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Report Description<br />
Rapidly spreading infectious diseases such as tuberculosis, malaria, Hepatitis B, HIV/AIDS,<br />
influenza and others are becoming major concern to the society and the healthcare<br />
professionals as they are majorly contributing to worldwide causes of death and presenting<br />
huge burden on healthcare systems. Infectious diseases are treated with category of drugs<br />
including antivirals and anti-infective agents along with adjunct therapy of immune system<br />
boosters. <strong>Anti</strong>-infective vaccines are the most powerful health measure taken by the healthcare<br />
systems to prevent the rapidly spreading infectious diseases. Infectious diseases being a<br />
substantial health threat, numerous companies are trying to innovate novel anti-infective<br />
vaccines to combat patient burden on medical managements. <strong>Anti</strong>-infective vaccines for the<br />
prophylaxis of diseases such as influenza (Fluarix, Fluzone, FluMist), hepatitis (Recombivax HB,<br />
Havrix, Engerix-B), malaria (RTS,S), polio (IPOL), tuberculosis (BCG) are readily available in<br />
market. <strong>Anti</strong>- infective vaccines for some infectious diseases such as polio and tetanus are given<br />
to child after birth under the national immunization programs.<br />
<strong>Anti</strong>-infective vaccines <strong>Market</strong>: Drivers and Restraints<br />
Increasing incidence of infectious diseases, incidence of new emerging diseases, bioterrorism<br />
and resistance to existing anti-infective therapies are the major drivers for the growth of global<br />
anti-infective vaccines market. Moreover, growing awareness for infectious disease diagnosis,<br />
increasing health consciousness, advancements in medical technology, thriving demands for<br />
control on infectious diseases are some other factors expected to flourish the growth of global<br />
anti-infective vaccines market. However, unavailability of anti-infective vaccines in some
Report Description<br />
underdeveloped regions and high prizes of immunization can be the hurdles in the growth of<br />
global anti-infective vaccines market.<br />
<strong>Anti</strong>-infective vaccines <strong>Market</strong>: Segmentation<br />
The global anti-infective vaccines market has been segmented on the basis of product type,<br />
disease type end users and geography.<br />
Based on product type, the global anti-infective vaccines market is segmented into following:<br />
• Live/attenuated <strong>Vaccines</strong><br />
• Inactivated <strong>Vaccines</strong><br />
• DNA & recombinant vector <strong>Vaccines</strong><br />
• Others (subunit, conjugate, toxoid vaccines)<br />
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-<br />
1353<br />
Based on disease type, the global anti-infective vaccines market is segmented into following:<br />
• Bacterial diseases<br />
• Typhoid <strong>Vaccines</strong><br />
• Tuberculosis <strong>Vaccines</strong><br />
• Tetanus & Diphtheria <strong>Vaccines</strong><br />
• Others (anthrax, plague etc.)
Report Description<br />
• Viral Diseases<br />
• Influenza <strong>Vaccines</strong><br />
• Hepatitis <strong>Vaccines</strong><br />
• Polio Vaccine<br />
• Others (rabies, zoster etc.)<br />
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1353<br />
Based on the distribution channel, the global anti-infective vaccines market is segmented into<br />
the following:<br />
• Hospitals Clinics<br />
• Public Hospitals<br />
• Private Clinics<br />
• Retail Pharmacies and Drug Stores<br />
• e-commerce<br />
<strong>Anti</strong>-infective vaccines <strong>Market</strong>: Overview<br />
The global anti-infective vaccines market possesses a high growth potential owing to ongoing<br />
researches and studies by government as well as research institutes for the development of<br />
prophylactic vaccines for various infectious diseases. <strong>Market</strong> for viral diseases vaccines is likely<br />
to hold major share in global anti-infective vaccines market due to threat of treating the disease.
Report Description<br />
Government vaccination centers end user segment majorly contributes to the global antiinfective<br />
vaccines market volume due to strong patient pool towards national immunization<br />
programs.<br />
<strong>Anti</strong>-infective vaccines <strong>Market</strong>: Regional Wise Outlook<br />
Geographically, the global anti-infective vaccines market is classified into regions viz. North<br />
America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and<br />
Africa. North America anti-infective vaccines market is estimated to lead the global anti-infective<br />
vaccines market due to existence of highly planned healthcare reimbursement schemes and<br />
higher purchasing power for expensive vaccines. Additionally, APAC and MEA anti-infective<br />
vaccines market are expected to grow rapidly during the forecast period because of rising<br />
national healthcare expenditure and urge to prevent the spread of infectious diseases<br />
<strong>Anti</strong>-infective vaccines <strong>Market</strong>: Key Players<br />
Some of the major players in the global anti-infective vaccines market are Barr Labs, Inc.,<br />
Emergent BioDefense Operations Lansing Inc., Organon Teknika Corp LLC, Sanofi Pasteur, Inc.,<br />
GlaxoSmithKline Biologicals, Merck & Co, Inc., CSL Limited, MedImmune LLC, ID Biomedical<br />
Corp., Novartis <strong>Vaccines</strong> and Diagnostics Limited, Protein Sciences Corporation, Intercell<br />
Biomedical, Wyeth Pharmaceuticals, Inc., MassBiologics, Berna Biotech, Ltd. and others.<br />
Numerous companies such as GlaxoSmithKline Pharmaceuticals Ltd., VaxGen etc. are engaged in<br />
the development of HIV vaccines which are expected to launch in near future.
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and<br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports and country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research<br />
Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Subscription Information<br />
Sector Coverage<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - <strong>Global</strong> Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
• Automotive and Transportation<br />
• Chemicals & Materials<br />
• Electronics, Semiconductor, and ICT • Food and Beverages<br />
• Retail and Consumer Products<br />
• Services and Utilities<br />
• Industrial Automation and Equipment • Energy, Mining, Oil, and<br />
• Healthcare, Pharmaceuticals & Medical Devices Gas
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For other queries contact:<br />
Future <strong>Market</strong> Insights 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language